Academic Malignant Hematologist – Myeloma

Clinical Area: Hematology
Organization: Princess Margaret Cancer Centre, University Health Network

Academic Malignant Hematologist – Myeloma
Princess Margaret Cancer Centre, University Health Network
Assistant/Associate/Full Professor
Clinician Scientist

The Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre, University Health Network (UHN) is seeking to recruit an energetic and innovative physician with expertise in malignant hematology with a focus on Myeloma. The successful applicant must be eligible for a Full Time Clinical Academic appointment at the rank of Assistant Professor or higher, and will have an academic position description of Clinician Scientist. The anticipated start date is January 01, 2023, or shortly thereafter.

The successful applicant will join a multidisciplinary team in the management of Plasma cell dyscrasias including the management of multiple myeloma, AL amyloid, POEMS, MGRS and waldenstrom macroglobulemia and the application of autologous stem cell transplant as well as CART cell therapy in their managements within a comprehensive cancer centre setting and, will be expected to engage in clinical, translational, or basic science research. Other responsibilities include teaching at the undergraduate and postgraduate levels.

Ranked in the top 10 on Newsweek’s list of the World’s Best Specialized Hospitals for Oncology in 2023, the Princess Margaret Cancer Centre continues to be on the frontiers of medical, surgical and radiation oncology, embracing the latest technology and international best-practices and setting standards for patient care. The Princess Margaret Cancer Centre includes the Ontario Cancer Institute (OCI), while Sinai Health System includes the Lunenfeld-Tanenbaum Research Institute. These are world-class basic and translational research institutes with particular strengths in Genomics, Immunology, Stem Cell Biology, Cancer Biology, and Cell Therapeutics. The close association between clinicians and scientists within both institutions provides the opportunity for collaborations on disease biology and the development of innovative and informative translational studies, allowing for exceptional bench-to-bedside medicine. In addition, the Princess Margaret Cancer Centre and Sinai Health System support active and widely recognized clinical trials and drug development programs and maintains a state-of-the-art GMP cell processing facility. Both institutions are affiliated with the University of Toronto, which is world-recognized for programs in areas including Biochemistry, Immunology, Stem Cell Biology, Genomics, Proteomics, and Cell Processing, among others. Princess Margaret Cancer Centre and Sinai Health System are teaching hospitals, dedicated to educating the world’s future top cancer experts. Our role as internationally respected teaching hospitals keeps us and our students abreast of the latest medical developments and the most advanced technology.

Comprised of about thirty senior physicians, the Malignant Hematology Program is supported by outstanding institutional infrastructure including hematopathology, cytogenetics and molecular diagnostics programs facilitated by a wide medical and allied health multidisciplinary team. The program supports extensive clinical, translational, and basic research initiatives including a broad ranging phase I, II and III clinical trials program. Additionally, the Division of Medical Oncology and Hematology supports a comprehensive training program attracting both national and international fellows.

The successful candidate will fulfil the academic position description of Clinician Scientist. The successful applicant will demonstrate the passion and vision to fulfill UHN’s mandate, fostering innovative and collaborative multi-disciplinary, multi-departmental and international educational and quality improvement initiatives. Scholarly excellence will be assessed by the presence of research grants, publications in leading journals, invited presentations at significant conferences, awards, accolades, and other related accomplishments. The successful applicant must hold a MD degree as well as specialist designation in Clinical Hematology or Medical Oncology, or equivalent. Each successful applicant must also have, or be eligible for both registration with the College of Physicians and Surgeons of Ontario and FRCPC qualifications or equivalent and have, or be eligible for licensure in Ontario. Academic rank, salary and contractual arrangements will be commensurate with the qualifications and experience of the successful candidate. A highly attractive remuneration package is available.

Should you be interested in this exciting opportunity, please forward your covering letter, curriculum vitae, and the names and addresses of three (3) referees to:
Dr. Amit Oza – Chief, Division of Medical Oncology and Hematology
C/o Christina Gulesserian –Administrative Coordinator
Princess Margaret Cancer Centre, University Health Network
Suite 700U: 7-925, 610 University Avenue, Toronto, Ontario, Canada, M5G 2M9 Office: 416-946-4501 ext 5503
Fax: 416.946.2082 E-mail: [email protected]

Applications will be accepted until all positions are filled.

For more information on the Princess Margaret Cancer Centre and our world-recognized programs, visit:

For more information on Sinai Health and our world-renowned programs, visit:

For more information about the Department of Medicine at the University of Toronto, please visit our website at The Department of Medicine’s academic position descriptions can be viewed on this webpage:

All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority.

Diversity Statement
The University of Toronto, University Health Network and Sinai Health System are strongly committed to diversity within its community and especially welcomes applications from racialized persons/persons of colour, women, Indigenous / Aboriginal People of North America, persons with disabilities, LGBTQ2S+ persons, and others who may contribute to the further diversification of ideas.

Accessibility Statement
The University strives to be an equitable and inclusive community, and proactively seeks to increase diversity among its community members. Our values regarding equity and diversity are linked with our unwavering commitment to excellence in the pursuit of our academic mission. The University is committed to the principles of the Accessibility for Ontarians with Disabilities Act (AODA). As such, we strive to make our recruitment, assessment and selection processes as accessible as possible and prove accommodations as required for applicants with disabilities. If you require any accommodations at any point during the application and hiring process, please contact [email protected]